NEWSFLASH Our #Fight4Treatment has made The Daily Express newspaper today with an compelling interview with Samantha-Jayne Harding, mum of Toby-Jay, who has TSC, of Westcliff. If you would like to sign our e-petition then please click here.

  We are thrilled to be able to tell you that this year we are fielding our biggest number of runners ever to tackle the iconic Great North Run for us on Sunday, September 11. Here is a list of all our 17 Great North runners,

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Prasent ac nibh vestibulum, laoreet ipsum.

Our #Fight4Treatment campaign has also been featured on BBC Radio York this morning. You can find out more, and listen to the radio report, here: http://www.bbc.co.uk/news/live/uk-england-york-north-yorkshire-37610513

Our #Fight4Treatment was featured on page 62 of the Mail on Sunday, October 9 - you can read it on the link here. http://www.dailymail.co.uk/health/article-3828549/NHS-accused-abandoning-children-life-threatening-disease-refusing-funds-breakthrough-drug-not-currently-affordable.html            

Julian Sturdy MP Leads Cross Party Group of MPs Lobbying NHS England Over Much-Needed Everolimus Drug A cross-party group of MPs, led by Julian and Greg Mulholland, have written to NHS Chief Executive Simon Stevens urging him to make the Everolimus drug available to those

Please note that from December 23, 2016 to January 3, 2017 we will be offering a reduced cover service.  Should you need to contact a TSA  Adviser, or any other member of staff, over the Christmas and New Year period, please call, or email, that

The European Patients Academy on Therapeutic Innovation (EUPATI) has developed a toolkit to provide information for anyone who is interested in learning more about the medicines research and development (R&D) process. More information can be found in the downloads page of the TSA website: http://www.tuberous-sclerosis.org/download-resources-library.html

Patient experiences of Individual Funding Requests (IFRs) survey. Have you accessed a treatment for TSC through an Individual Funding Request (IFR)? Have you failed to gain access to a treatment that you need via an IFR? Genetic Alliance UK is looking to hear from patients

We are delighted to announce that NHS England will now routinely fund Everolimus for inoperable TSC brain tumours (SEGA). This means that NHS England have reversed their previous decision made this summer when they had reached a decision that Everolimus was ‘unaffordable’. Jayne Spink, Chief